Found 14 matching trials
EUS-guided RFA for Pancreatic Neoplasms
NARadiofrequency ablation has been used for treatment of solid neoplasms of t...
Location
Department of Surgery, Prince of Wales Hospital
Endoscopic Ultrasound Radiofrequency Ablation for GISTs
NANowadays, for the selection of the treatment for gastrointestinal stromal t...
Location
Instituto Ecuatoriano de Enfermedades Digestivas (IECED)
Combine TACE and RFA Versus TACE Alone for HCC With PVTT
PHASE3The purpose of this study is to determine whether combined radiofrequency a...
Location
Minimally Invasive Interventional Division, Medical Imaging Center, Sun Yat-sen University Cancer Center,
Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors
NAThe primary aim of this study is to evaluate the technical feasibility and ...
Location
Institute for Clinical and Experimental Medicine, Department of Gastroenterology and Hepatology
Radiofrequency Ablation in TIR3A Nodules With Negative Genetic Evaluation
NAThe goal of this clinical trial is to demonstrate that TIR3A nodules with n...
Location
Istituto Auxologico Italiano IRCCS
RFA for Superficial Lipomas
NALipomas are non-cancerous growths of fatty tissue that develop under the sk...
Location
Columbia University Irving Medical Center
Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors
NAPancreatic radiofrequency ablation (RFA) could therefore be an alternative ...
Location
Institut Paoli Calmettes
Radiofrequency Ablation for Biliopancreatic Malignancy
PHASE2This phase-2 study aims to evaluate feasibility, safety and efficacy of the...
Location
University Hospitals Leuven
Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCC
NAThis phase 3 study is to evaluate the effectiveness of the comparison betwe...
Location
National Cancer Center, Korea
Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma
NAThis international, multicenter, open-label randomized controlled trial eva...
Location
Aichi Medical University